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DNA damage signaling pathways are initiated in response to chemical reagents and radiation damage, as well as in response to
hypoxia.It isimplicated thatstructuralmaintenanceofchromosomes1(SMC1) isnotonlyacomponent ofthecohesioncomplex
but also facilitates the activation of DNA damage checkpoint proteins. Here, we studied the mechanism of DNA damage
checkpoint activated by ATR–SMC1 pathway when cells are treated with desferrioxamine (DFO), a hypoxia-mimetic reagent. We
showthatDFOtreatmentinducesphosphorylationofSMC1atSer966,NBS1atSer343, Chk1atSer317,Chk2atThr68,andp53at
Ser15. Among these sites, phosphorylation of SMC1, NBS1, and Chk1 by DFO are mediated by ATR as it is greatly reduced in
both ATR-deﬁcient human ﬁbroblasts and HCT116 human colon cancer cells in which ATR is heterozygously mutated, whereas
these proteins are phosphorylated incellsdeﬁcientforATM andDNA-PKcs.DFO-inducedapoptosis is decreasedinATR-mutant
HCT116 cells, although p53 is normally activated in those cells. Expression of SMC1 S966A in which Ser966 is substituted to Ala
attenuates apoptosis and phosphorylation of Chk1 at Ser317 after DFO treatment, although levels of HIF1a are not signiﬁcantly
changed. These results suggest that DFO induces apoptosis through the ATR–SMC1 arm of the pathway.
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Cellular DNA is continuously exposed to both external and
internal DNA insults such as UV- or ionizing radiation (IR),
chemicals, and oxidative stress. An appropriate response to
these DNA damage is essential for maintenance of genome
stabilitywhosedysfunctioniscausalforcancerdevelopment.
1
Mechanisms of sensing and repairing damaged DNA are
conserved among the species, supporting a notion that
regulation of this pathway sensing DNA stress is crucial for
the normal proliferation of the whole organism. When cells are
DNA damaged, sensor molecules in this system detect them
and activate the cell cycle checkpoint that induces growth
arrest, whereas these damages are repaired by a mechanism
such as homologous recombination or non-homologous end-
joining.
2,3 If not repaired properly, cells undergo apoptosis.
It is implicated that several protein kinases are involved in this
system, including ATM/ATR protein Ser/Thr kinases, and
DNA-dependent protein catalytic subunit (DNA-PKcs). ATM,
ATR, and DNA-PK belongs to phosphoinositide 3-kinase-
related kinase family and phosphorylates substrates, which
are essential to transduce checkpoint signals to downstream
effectors, those including the MRN (Mre11/Rad50/NBS1)
complex, Fanconi anemia proteins, and the BRCA1 breast
cancer tumor-susceptible protein.
4,5
Hypoxia is commonly and frequently observed in solid
tumors and results from the imbalance of oxygen supply and
consumption by successive layers of tumor cells because of
unregulated cell growth.
6 Because lesions of hypoxic tumor
tissues are resistant to treatment and are associated with a
poor clinical prognosis, tumor hypoxia is a main obstacle for
therapeutic strategies. Cellular hypoxia results in a rapid
reduction in ATP levels, activation of G1 phase cell cycle
checkpoint, inhibition of DNA replication, decreased protein
synthesis, and increased protein degradation.
7 Although
hypoxia itself seems to be insufﬁcient to induce DNA damage,
it can induce genetic instability through resistance to
apoptosis and decreased DNA repair in tumor tissue.
8 Once
DNA damage signaling pathways are initiated in response to
hypoxia and hypoxia reoxygenation, ATR protein is activated,
leading to phosphorylation of p53 and Chk1
9 ATM is also
required to phosphorylate p53 and activate G2 checkpoint
afterreoxygenation.
10Previousstudyshowedthat,incontrast
to IR-activated ATM, the hypoxia-induced activation of both




Structural maintenance of chromosomes (SMC) proteins
are evolutionarily conserved chromosomal proteins that are
components of the cohesion complex, necessary for sister
chromatid cohesion.
12 Also, SMC1, as a subunit of cohesion,
is not only activates DNA repair but also facilitates the
recruitment of checkpoint proteins, which activates the intra-S
and G2/M checkpoints, indicating that the activation of SMC1
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checkpoint, as well for intra-S checkpoint.
13 SMC1 is
phosphorylated at speciﬁc sites in response to IR in an
ATM-dependent manner, and it is shown that phosphorylation
of S957 and/or S966 of SMC1 is required for activation of the
S-phase checkpoint in response to IR.
14 The same residues
are phosphorylated after treatment with UV irradiation or
hydroxyurea (HU) in an ATM-independent manner. Recent
studies have also described that SMC1, together with other
checkpoint signaling proteins, including p53, 53BP1, and
Chk1/Chk2, was phosphorylated rapidly by ATR in ATM-
deﬁcient cell lines,
15 indicating that phosphorylation of SMC1,
under conditions of DNA stress, has a crucial role in DNA
damage response and subsequent activation of cell cycle
checkpoint. Although hypoxia and reoxygenation after
hypoxia also induce phosphorylation of Ser957 of SMC1 in
human lymphocyte,
16 the mechanisms and the role of
phosphorylated SMC1 in hypoxia remain unclear. Desferriox-
amine (DFO) is used to induce hypoxic condition in cell
culture, however, it is not well illustrated how it could activate
DNA damage pathway. In the present studies, by taking
advantageofasubsetofspeciﬁcmutantcelllines,wedetailed
how DFO activates DNA damage signaling. We describe that
DFO-induced phosphorylation of SMC1 at Ser966 and Chk1
at Ser317 was dependent on ATR protein kinase, whereas
HU- or neocarzinostatin (NCS)-induced phosphorylation of
SMC1 and Chk1 was not abrogated in ATR-mutant cells. We
show that expression of a phospho-deﬁcient form of SMC1,
SMC1S966A, can function as a dominant-negative molecule
in DFO-induced apoptosis. These results suggest that
phosphorylation of SMC1 at Ser966 by ATR has an essential
role in inducing apoptosis under hypoxia conditions.
Results
DFO treatment induces phosphorylation of SMC1. It has
previously been demonstrated that hypoxia condition
generated by DFO, a hypoxia-mimetic and antioxidant
agent, could induce p53-dependent checkpoint signaling in
human peripheral blood lymphocytes.
17 We started to detail
how DFO activates DNA damage pathway. Human colorectal
carcinoma HCT116 cells were treated with DFO at different
concentrations for 24h, followed by treatment with either
IR-mimetic agent NCS that can produce double-stranded
breaks,
4 or DNA replication inhibitor HU for 30min or 1h
(Figures 1a and b). Cells were collected and total lysates
were subjected to western blotting with antibodies for DNA
damage-responsive proteins. It is well illustrated that
phosphorylation of ATM Ser1981 is a readout of its
activation.
18 NCS treatment weakly induced phosphory-
lation of ATM at Ser1981 in HCT116 cells (Figure 1a, lanes
2 and 3), but no signiﬁcant phosphorylation was detected in
DFO- and HU-treated HCT116 cells (Figure 1b).
Phosphorylation of NBS1at Ser343 was also weakly
induced by DFO and NCS (Figure 1a), but no additive or
enhanced phosphorylation was observed by DFO plus either
NCS or HU (Figures 1a and b). Phosphorylation of Chk2 at
Thr68 was weakly induced by higher concentration of DFO
(300 and 500mM) after long exposure of autoradiography,
but it was much less than that induced by NCS treatment
(Figure 1a). This Chk2 phosphorylation was also induced by
HU alone, but it was similar to the levels those induced
by DFO treatment of high concentration (300 and 500mM)
(Figure 1b).
Among the DNA damage-associated proteins studied,
SMC1 was strongly phosphorylated at Ser966 by DFO, NCS,
and HU treatment. Of note, ATM’s activation is detected only
with NCS treatment, suggesting that ATM is not involved in
phosphorylation of SMC1 when cells are treated with DFO or
HU. Supporting this notion, it is shown that Ser966 of SMC1 is
phosphorylated by HU treatment through ATM-independent
manner, whereas IR-induced phosphorylation at this site
requires ATM and its substrates, such as NBS1 and BRCA1.
14
Together these results suggest that phosphorylation of SMC1
by DFO and HU does not require activation of ATM.
ATR is required for DFO-induced phosphorylation of
SMC1. Previous reports have shown that ATM and ATR
phosphorylate similar motifs of peptides under different
conditions of DNA stress.
19 Recent works have also
demonstrated that ATR is required for phosphorylation of
checkpoint proteins, such as p53, SMC1, and Chk1/2, after
IR in ATM-deﬁcient cells.
15 As we showed in Figure 1,
phosphorylation of SMC1 at Ser966 by DFO does not require
activated ATM. From these observations, we reasoned to
identify the kinase that is responsible for phosphorylation of
SMC1 at Ser966 when treated with DFO. We used three
different human ﬁbroblast cell lines, GM00200 (control,
ATM(þ), ATR(þ)), GM09607 (ATM( )), and GM18366
(ATR( )). When these cells were treated with DFO,
phosphorylation of SMC1 at Ser966 was detected in control
and ATM-deﬁcient cells, but it was greatly decreased in
ATR-deﬁcient cell (Figure 2). Although levels of SMC1
in GM18366 cells were lower than those in other two cell
lines, and levels of SMC1 in GM09607 cells were slightly
higher than those of GM00200 cells, NCS similarly induced
phosphorylation of SMC1 in three of these cell lines,
suggesting that this phosphorylation of SMC1 is ATM/ATR-
independent, or ATM and ATR compensate individual
deﬁciency. It is shown that phosphorylation of DNA-PKcs at
Ser2056 indicates the readout of activation of the catalytic
activity.
20 Although levels of DNA-PKcs among these three
cell lines were different, DFO-induced phosphorylation of
DNA-PKcs at Ser2056 was detected only in ATM-deﬁcient
cells. Phosphorylation of DNA-PKcs at this site in ATR-
deﬁcient cells, induced by NCS, was much weaker than
those detected in control and ATM-deﬁcient cells.
We further detailed the phosphorylation of SMC1 and other
proteins involved in DNA damage pathway using isogenic
HCT116 cell lines, those including HCT116-p53( ),  DNA-
PKcs( ),andATR( /ﬂox).
21–23InHCT116-ATR( /ﬂox)cells,
one allele of the ATR gene is deleted and the other allele is
ﬂoxed,resulting in signiﬁcantly decreasedlevels ofthe protein
(Figure 3b and see Moynahan and Jasin
3). Parental HCT116
cells and their isogenic cell lines were treated with DFO, HU,
or NCS for 24h (Figures 3a–c). Consistent with the results
from human ﬁbroblasts (Figure 2), DFO treatment did not
signiﬁcantly induce phosphorylation of SMC1 at Ser966 in
HCT116-ATR( /ﬂox)cells,eventhough low levelsofATR are
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Cell Death and Diseasestill expressed in those cells (Figure 3a, lanes 4 and 5, and
Figure 3b, lanes 7 and 8). As shown in previous studies,
11 we
observed reduced level of ATM protein in DNA-PKcs( ) cells
compared with parental HCT116 (data not shown).
Nevertheless, phosphorylation of SMC1 at Ser966 in
HCT116-DNA-PKcs( ) cells was similarly induced to the
levels of the parental HCT116 cells in response to these three
chemicals (Figures 3a and b). This phosphorylation of SMC1
induced by NCS was weaker in HCT116-ATR( /ﬂox) cells,
compared with the parental and HCT116-DNA-PKcs( ) cells
(Figure 3a, lanes 6 and 9). Interestingly, phosphorylation of
Chk2 at Thr68 by DFO was not detected in HCT116-DNA-
Pkcs( ) cells, indicating that DNA-PKcs is essential for this
phosphorylationofChk2(Figure3c).Ofnote,phosphorylation
of p53 at Ser 15 and Ser20 is similarly induced by DFO and
HU in parental HCT116, HCT116-ATR( /ﬂox), and HCT116-
DNA-PKcs( ) cells (Figure 3b). As DFO is a hypoxia-mimetic
reagent, treatment of these HCT116 variants with DFO
induced HIF1a as previously reported,
24 although levels of
an induced protein are different among these four cell lines.
These results implicate that DFO activates two arms of
signaling pathways. Thus, one is to phosphorylate SMC1 at
Ser966, NBS1 at Ser343, and Chk1 at Ser317 in an ATR-
dependent manner, and the other is to phosphorylate Chk2 at
The68 in DNA-PKcs-dependent manner.
ATR is necessary for DFO-induced apoptosis. It is shown
that anoxia or hypoxia induces a G1 and intra-S phase
arrest.
10 As DFO is widely used to induce hypoxia condition
in cell culture,
25 we studied the role of ATR in DFO-induced
Figure 1 DFOtreatmentinduces phosphorylation of DNA damageresponseproteins.HCT 116cellswere treatedwith DFOfor 24h at indicatedconcentrations,andthen
further treated with NCS (0.5mg/ml) (a) or HU (3mM) (b) for the indicated times. Total cells extracts were cleared and 20mg of proteins were subjected to a 6% SDS-PAGE
gel. After transferring to PVDF membranes, phosphorylation of indicated proteins was assayed by western blotting with phospho-speciﬁc antibodies as indicated. The results
of immunoblots were analyzed by densitometry. The numbers under blots show the relative densitometry ratios of phosphoprotein to total protein. Actin protein was used as
internal loading control; ND, not detected
Figure 2 DFO induces phosphorylation of SMC1 is lowered in ATR-deﬁcient
ﬁbroblasts. GM00200 (wild type), GM09607 (ATM( )), and GM18366 (ATR( ))
human ﬁbroblast were treated with NCS (0.5mg/ml) or DFO (300mM) for 24h and
assayed by western blotting with anti-phospho antibodies for DNA-PKcs Ser2056,
ATM Ser1981, and SMC1 Ser966. Actin protein was a loading control. The level of
phosphorylated protein was analyzed by densitometry as described in Figure 1
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Cell Death and Diseasecell cycle checkpoint. Parental, HCT116-p53( ), HCT116-
DNA-PKcs( ), or HCT116-ATR( /ﬂox) cells were treated
with DFO or HU for 24h and collected, then stained with
propidium iodide (PI) for cell cycle analysis using ﬂow
cytometer (Figure 4).
After DFO treatment, increase in S-phase was most
obvious in the parental HCT116 (from 22.4 to 28.8%), not in
others. Instead, HCT116-p53( ), HCT116-ATR( /ﬂox), and
HCT116-DNA-PKcs( ) cells showed increase in G1 phase.
Population in S-phase in HCT116-p53( ), HCT116-ATR
( /ﬂox), and HCT116-DNA-PKcs( ) cells did not change
signiﬁcantly with DFO treatment compared with their
individual untreated control, but numbers of cells in G2/M
phase were greatly reduced with this treatment.
When cells were treated with HU, all of these cell types
showed signiﬁcant increase in S-phase, although HCT116-
DNA-PKcs( ) cells showed less accumulation in S-phase
(47.4%) than other cells (HCT116 cells, 55.7%; HCT116-
p53( ) cells, 55.1%; HCT116-ATR( /ﬂox) cells, 55.2%).
We further detailed the role of ATR and phosphorylation of
SMC1 at Ser966 in regulating apoptosis, in particular.
HCT116-ATR( /ﬂox) cells were transfected with a plasmid
expressing Cre-recombinase fused with GFP protein
(Cre-GFP) to delete the remaining ATR allele. Cells were
Figure 3 DFO phosphorylates SMC1, NBS1, and Chk1 in ATR-dependent manner. Parental HCT116 (wild type), HCT116-p53( ), HCT116-ATR( /ﬂox), and HCT116-
DNA-PKcs( ) cells were treated with DFO (300mM) or NCS (0.5mg/ml), or HU (3mM) for 24h, and then total extracts were studied for western blotting. Phosphorylation of
indicated proteins was compared when cells are treated with (a) NCS and DFO, and (b) HU and DFO. (c) Phosphorylation of NBS1 and Chk2 by DFO were compared
inisogenicHCT116celllines.Actinwasusedforaloadingcontrol.ThelevelofphosphorylationofSMC1,NBS1,p53,Chk1,andChk2wasexpressedbydensitometryratiosof
phosphoprotein to total protein. The expression of ATR protein in these cells was measured by ratio of ATR to actin protein (b)
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Cell Death and Diseasethen treated with DFO, NCS, or HU for 24h, followed by
Annexin V staining to measure apoptosis (Figure 5a). DFO
treatment induces apoptosis in parental HCT116 cells by
B2.5-fold (from 11.6 to 29.4%). Basal levels of apoptosis of
Cre-transfected HCT116-ATR( /ﬂox) are higher (17.8%)
than parental HCT116 cells (11.6%), indicating that the loss
of both the alleles of ATR is intrinsically apoptotic. Level of
apoptosisofHCT116-ATR( /ﬂox)cellswasslightlyincreased
(23.9%) after DFO treatment (B1.3-fold) (Figure 5a). When
Cre-GFP-transfected HCT116 cells were treated with either
NCS or HU, induction of apoptosis was B2.4- and B2.0-fold,
respectively. Levels of apoptosis of Cre-GFP-transfected
CT116-ATR( /ﬂox) cells, treated with NCS and HU, were
similar to those of parental HCT116 cells by B2.3- and B2.0-
fold,respectively.Theseresultsare schematicallyindicatedin
Figure 5b. These results demonstrate that DFO-induced
apoptosis is signiﬁcantly reduced when ATR is inactivated.
ATR-dependent phosphorylation of SMC1 at S966 is
required for DFO-induced apoptosis. On the basis of the
results demonstrated in Figure 1, we hypothesized that this
ATR-mediated phosphorylation of SMC1is involved in DFO-
induced apoptosis that is shown in Figure 5. We explored
transient expression of a phospho-deﬁcient mutant form of
SMC1 in cell culture. 293T cells and HCT116 cells were
transfected with an empty vector or a plasmid expressing a
Myc-tagged mutant SMC1 in which Ser966 is substituted by
Ala (SMC1S966A) (Figures 6a and b, see Kim et al
14), and
we analyzed apoptotic phenotype after DFO treatment. The
expression of mutant SMC1 was conﬁrmed by immuno-
blotting of anti-Myc antibody. As described in Figure 3,
phosphorylation of both Chk1 at Ser317 and NBS1 at Ser343
were induced with DFO treatment in both cell types, but it
was weakly decreased in when SMC1S966A was expressed
(Figure 6a, lanes 2 and 6; Figure 6b, lanes 2 and 5). It is well
illustrated that hypoxia condition induces HIF1a,a
transcription factor that has an essential role in cellular and
systemic responses to hypoxia.
25 As shown in Figure 6a,
DFO induced HIF1a in 293T cells, and levels of HIF1a were
not signiﬁcantly changed when SMC1 S966A was expressed
(Figure 6a, lanes 2 and 6).
To further elucidate the biological roles of SMC1 pathway,
we studied whether DFO-induced apoptosis could be modu-
lated by expressing a phospho-mutant form of SMC1,
SMC1S966A. After transient transfection of both 293T cells
and HCT116 cells with SMC1S966A, cells were treated with
DFO, and apoptosis was measured by Annexin V staining. As
shown in Figures 6c and d, expression of SMC1S966A
inhibited induction of apoptosis. Inhibition of apoptosis by
SMC1S966AinHCT116cellswasnotasmuchasthatin293T
cells probably because of lower levels of expression of the
protein. To conﬁrm this, levels of Myc-tagged SMC1S966A
were compared between HCT116 and 293T cells, and
phosphorylation of SMC1 at Ser966 was detected
(Figure 6e). As indicated, levels of exogenous SMC1S966A
Figure 4 DFO induced cell cycle arrest in wild-type HCT116 cells and isogenic
cell lines. Cells were treated with DFO (300mM) or HU (3mM) for 24h. Cell cycle
wasquantiﬁedbysingle-parameterﬂowcytometryafterPIstainingforDNAcontent.
Graphs represent percentages of cells in sub-G1, G1, S, and G1/M phases of cell
cycle. Data shown here are representative of three experiments performed
Figure 5 Effect of ATR deﬁciency on DFO-induced apoptosis. Parental
HCT116 and HCT116-ATR( /ﬂox) cells were transfected with a plsmid expressing
Cre-GFP fusion protein or a control vector (not shown). At 48h after transfection,
cellsweretreatedwithDFO(300mM),NCS(0.5mg/ml),orHU(3mM)for24h.Cells
were stained with Annexin V with PI counter staining. Green ﬂuorescence-positive
and -negative cells were gated and separately analyzed using FACSCalibur ﬂow
cytometer. (a) Percentage of dot plot represents one of the three independent
experiments. (b) Induction of apoptosis of HCT116 and HCT116-ATR( /ﬂox) cells
by DFO, NCS, or HU was indicated as a bar graph. Data were expressed fold
induction compared with mock-treated samples
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Cell Death and Diseasewere higher in 293T cells, and phosphorylation of SMC1 at
Ser966 was sufﬁciently inhibited in those cells compared with
HCT116 cells.
These results indicate that SMC1S966A functions as a
dominant-negative protein for DFO-induced apoptosis, and
suggest that ATR-mediated phosphorylation of SMC1 at
Ser966 is important for this phenotype.
Discussion
Activation of DNA damage response occurs when cells are
exposed to a series of stresses, such as IR, UV, and hypo- or
hyperoxidative conditions. DFO, which is used to induce
hypoxia conditions, has genotoxic effects on human lympho-
cytes cell culture,
17 and induces apoptosis through the
p38/caspase 8/Bid/Bax pathway,
24 whereas anti-apoptotic
functions of DFO has also been observed in erythrocytes.
26
Thus, regulation of apoptosis by DFO is cell context-
dependent. In the current study, we investigated DFO-
inducedDNAdamagepathway andcharacterized phosphory-
lation of proteins that are involved in apoptosis.
It is reported that phosphorylation of SMC1 at Ser966 does
not occur immediately under conditions of hypoxia, and is
detected after 8h when human lymphocytes were exposed to
hypoxia condition.
16 Consistent with this, we found that
phosphorylation of SMC1 at Ser966 is detected at 24h after
DFO treatment, whereas the phosphorylation at the same
residue is detected and reaches to the peak within 30min
when cells are treated with NCS. Thus, phosphorylation of
SMC1 is differentially regulated by hypoxia from genotoxic
chemicals.
Interestingly, compared with NCS-induced phosphorylation
of ATM at Ser1981, occurring within 30min, this ATM
phosphorylation was not detectable when HCT116 cells were
treated with DFO. Levels of phosphorylation of ATM at
Ser1981 were also low in U2OS human osteosarcoma cell
linewhentreatedwithDFO(datanotshown).Giventhestrong
phosphorylation of SMC1 at Ser966 by DFO treatment, it is
conceivable that this SMC1 is phosphorylated in an ATM-
independent manner. However, recent studies have
described that ATM is both phosphorylated and activated
during exposure to hypoxia and that a mechanism of this ATM
activation by hypoxia is independent of NBS1 and MRE11,
11
suggesting that mechanism of activation of DNA damage
pathway induced by hypoxia is different from that induced
by DFO.
It is shown recently that p53, SMC1, p53-binding protein
(53BP1), and Chk1/2 are phosphorylated by ATR in response
to IR in ATM-, Mre11-, and cell cycle-independent manners.
15
As demonstrated in Figure 2, we found that DFO-induced
SMC1 phosphorylation at Ser966 was signiﬁcantly lowered in
Figure 6 Transfection of 293T cells and HCT116 cells with S966A-mutant
SMC1 inhibited the DFO-induced apoptosis. (a) 293T cells and (b) HCT116 cells
were transfected with myc-tagged mutant SMC1 plasmid (Myc-SMC1S966A) or a
controlvector.After48h,cellsweretreatedwithDFO(300mM)orNCS(0.5mg/ml)
for additional 24h. Total extracts were studied for western blotting with indicated
antibodies to detect level of HIF1a and phosphorylated proteins of NBS1 S343P
and Chk1 at S317P. Actin blot serves as a loading control. (c) 293T cells and
(d) HCT116 cells were transfected with plasmid containing mutant SMC1 (Myc-
SMC1S966A) or a controlvector.After 48h, cells weretreatedwith DFO(300mM)
for additional 24h and then apoptosis was analyzed using a ﬂow cytometer (left
panel). Dot plot represents two independent experiments, indicating Annexin V
staining (right panel). DFO-induced apoptosis was expressed as fold-induction
compared with untreated samples (right panel, *Po0.05, Student’s t-test).
(e)LevelsofMyc-taggedSMC1S966A andphosphorylationof endogenous SMC1
at Ser966 were compared in HCT116 and 293T cell lines. The phosphorylation
andexpressionofproteinswereanalyzedbydensitometryasdescribedinFigure1
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Cell Death and DiseaseATR-deﬁcient ﬁbroblasts, but not in ATM-deﬁcient cells.
Phosphorylation of SMC1 at Ser966 by NCS was detected
in HCT116-ATR( /ﬂox) cells, although it is slightly weaker
than the other cell lines examined. Given that this phosphory-
lation of SMC1 by DFO is greatly reduced in HCT116-ATR
( /ﬂox) cells, these results implicate that ATR is critical for
SMC1’s phosphorylation in DFO pathway. Recent studies
have illustrated that phosphorylation of SMC1 is required for
the activation of S-phase checkpoint after IR, and phosphory-
lationofNBS1isessentialforthisphosphorylation ofSMC1.
27
Our results showed that DFO induces strong phosphorylation
of SMC1 at Ser966, although phosphorylation of NBS1 at
Ser343 is quite low in wild-type ATR cells (Figure 1). Taken
together, we consider that SMC1 can be activated by at least
two distinct pathways, one is ATM/NBS1/SMC1 in response
to IR and the other is ATR/SMC1 in response to DFO
(Figure 7).
Our results demonstrated that phosphorylation of Chk2 at
Thr68 is impaired in DFO-treated HCT116-DNA-PKcs( )
cells. Recent studies have shown that inactivation of DNA-
PKcs by siRNA or kinase inhibitor, Nu7026, results in
dysfunction of mitotic checkpoint and attenuation of Chk2
phosphorylation at Thr68 in response to IR.
28 Together with
our results, both DFO and IR may activate DNA-PKcs to
induce phosphorylation of Chk2.
In 293T cells expressing SMC1 S966A, phosphorylation of
Chk1atSer317wasslightlyloweredbutHIF1alevelswerenot
changed signiﬁcantly after DFO treatment compared with
control cells. Induction of HIF1a by DFO was detected in all of
the isogenic HCT116 variants examined, although HCT116-
ATR( /ﬂox) cells constitutively underwent apoptosis even
without DFO treatment. Therefore, it remains to be elucidated
whether induction of HIF1a is essential for DFO-induced
apoptosis. Thus, it is suggested that DFO induces apoptosis
in ATR/Chk1-dependent but not in HIF1a-independent
pathway.
It remains to be clear how phosphorylated SMC1 produces
apoptotic signals. Although it is well known that the phosphory-
lationofSMC1isrequiredfortheIR-inducedS-phasecellcycle
checkpoint
14 and also associated with G2/M checkpoint as a
subunit of cohesion with SMC3,
13 these studies have not
directly addressed how SMC1 regulates apoptosis. As one
possible model, it is plausible that SMC1 phosphorylated at
Ser966 speciﬁcally binds to subsets of cellular proteins,
generating proapoptotic complex. This model is raised by
recent studies demonstrating that SMC1 phosphorylated at
both Ser957 and Ser966 preferentially binds to Rae1, a
microtubule-bound RNA export factor 1, at the mitotic spindle
pole.
29 These studies suggest that phosphorylation status of
SMC1 can determine its intermolecular interaction with cellular
components. Identiﬁcation of proteins that preferentially binds
to phosphorylated SMC1 is in progress.
Materials and Methods
Cells,chemicals,andplasmids. GM00200(control),GM09607(ATM( )),
GM18366 (ATR( )) human ﬁbroblast cell lines were obtained from the National
Institute of General Medical Sciences Coriell Cell Repositories (Camden, NJ, USA).
Parental HCT-116, HCT116-ATR( /ﬂox) were purchased from ATCC (Manassas,
VA,USA),HCT116-p53( )cellsare providedbyDr.B Vogelsteinat JohnsHopkins
University, and a DNA-PK-mutant HCT116 cell line (HCT116-DNA-PKcs( )) was
kindly provided by Dr. E Hendrickson at University of Minnesota Medical School. All
of these cell lines were grown in DMEM media (Invitrogen, Carlsbad, CA, USA)
containing 10% fetal bovine serum (Invitrogen), penicillin/streptomycin and 10mM
sodium pyruvate (Sigma, St. Louis, MO, USA). Desferrioxamine mesylate (DFO)
was obtained from Calbiochem (La Jolla, CA, USA). HU and NCS were purchased
from Sigma. Myc-tagged wild-type SMC1 and S966A-mutant SMC1 expression
vectors were gratefully provided by Dr. M Kastan (St. Jude Children’s Research
Hospital, Memphis, TN, USA) and pCAG-Cre-GFP expression vector was
purchased from Addgene (Cambridge, MA, USA).
Immunoblotting and protein assays. Cells were treated with DFO (100,
300, or 500mM) for 24h, followed by HU (3mM), or NCS (0.5mg/ml) for the
indicated time, and then lysed in ice-cold lysis buffer (50mM Tris-HCl (pH 7.6),
150mMNaCl,1mMEDTA(pH8.0),20mMNaF,1mMNa3VO4,1%NP40,0.5mM
dithiothreitol) in the presence of protease–inhibitor mix (leupeptin, aprotinin, and
PMSF, 10mg/ml, respectively). After centrifugation (12000g, 10min), soluble
supernatants were prepared and protein concentrations were calculated using the
Bio-Rad protein assay kit (Bio-Rad, Hercules, CA, USA). Total cell lysate (20mg)
was loaded and separated by 6.0% SDS-polyacrylamide gels. Transfer to a PVDF
membrane (Immobilon-P, Millipore, Billerica, MA, USA) was carried out using semi-
dry transfer method (Trans-Blot, Bio-Rad) in 25mM Tris, 192mM glycine, and 10%
methanol for 1h at 20V. Membranes were blocked in 5% non-fat dried milk in
Tris-buffered saline/0.1% Tween-20 and incubated with primary antibodies and
Horseradish peroxidase-conjugated secondary antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) followed by enhanced chemiluminescence
detection. Primary antibodies used in this study were anti-ATM (GeneScript,
Piscataway, NJ, USA), anti-SMC1, anti-NBS1, anti-Chk1/2 (Santa Cruz
Biotechnology), and anti-p53 (Cell Signaling Technology, Danvers, MA, USA). Also
speciﬁc anti-phosphorylation antibodies were used against phospho-ATM (Ser1981,
Cell Signaling), phospho-SMC1 (Ser966, Bethyl Laboratories, Montgomery, TX,
USA), phospho–NBS1 (Ser345), phospho-Chk1 (Ser317), phospho-Chk2 (Thr38),
and phospho-p53 (Ser15 and Ser20, Cell Signaling Technology). Anti-actin antibody
(Santa Cruz Biotechnology) was used to validate protein amount.
Flow cytometric analysis for cell cycling arrest and
apoptosis. Cells were exposed to different concentrations of DFO (300mM),
NCS (0.5mg/ml), or HU (3mM) for 24h. Cell cycle arrest was assessed by ploidy
analysis after DNA staining with PI as previously described.
30 Brieﬂy, cells were
trypsinized, washed with cold PBS, and then ﬁxed with ice-cold 70% ethanol and
precipitated for 2h at ice. After ﬁxation, cells were suspended in room temperature
PBS, treated with RNaseA (50mg/ml), and then incubated for 30min at 371C
followed by stained with PI (50mg/ml). Samples were analyzed using FACSCalibur
Figure 7 Schematic presentation of pathways indicating SMC1 is involved in
DFO-induced apoptosis
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Cell Death and Diseaseﬂow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Apoptosis was
determined by Annexin V-FITC Apoptosis Detection Kit (EMD Chemicals,
Gibbstown, NJ, USA) according to manufacturer’s protocol. In addition to anti-
annexin-FITC antibody, PI was used to distinguish between viable, early apoptotic
and necrotic, or late-apoptotic cells. Chemical-induced apoptosis was determined
as fold induction compared with that in mock-treated cells. The data were analyzed
with CellQuestPro software (BD Biosciences).
Transfection. Transient transfection of both wild-type HCT 116 and HCT116-
ATR( /ﬂox) cells with a plasmid expressing Cre-GFP fusion protein was performed
for 48h with Lipofectamin 2000 (Invitrogen)accordingto manufacturer’s instruction,
followed by treatment with DFO or HU for 24h. Transfection efﬁciency was
monitored by green ﬂuorescent signals of Cre-GFP under the microscope. GFP-
negative cells were excluded by gating with side scatter (SSC) and Green
ﬂuorescent channel (FL1), and then GFP-positive/apoptotic cells were analyzed by
AnnexinV-APC Apoptosis detection kit (eBioscience, San Diego, CA, USA) and PI
according to manufacturer’s instruction.
Statistical analysis and densitometry. Data are shown as mean±S.D.
of one of the representative experiment from two to three independent experiments.
The signiﬁcance of differences in the mean values was determined by the two-tailed
unpaired Student’s t-test. P-values o0.05 were considered to be statistically
signiﬁcant. The level of phosphorylation and expression of proteins were measured by
densitometry using ImageJ software (National Institutes of Health) and the data were
expressed as arbitrary units relative to band intensity of total protein or internal control.
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